Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

Kathryn C. Zoon, Ph.D. (

...

1949–still living)

“I believe that CBER’s tradition of integrating innovative science with innovative regulations has enhanced our ability to protect the public health, and has led to safer and more effective biological products.”

  • — Kathryn Zoon

...

Known for her strong research skills, inspiring leadership abilities, and intelligent management style, Dr. Zoon became the first female director of CBER in 1992, a position she held through 2002. She took the helm at CBER during a time when they were receiving a remarkable number of new biotechnology product applications.

In 2002, she was elected to the National Academy of Medicine based on her contributions to public health and biotechnology.

In 2003 she She returned to the NIH in 2003 where she worked at the National Cancer Institute (NCI) as principal Deputy Director. She became the first female Scientific Director at NIH’s National Institute of Allergy and Infectious Disease (NIAID) Division of Intramural Research in 2006. In this role led staff in virology, immunology, product development and clinical research, returning and training new scientists, and providing future director for programs.

...

She worked in Building 29, Room 130 and Building 29A, second floor.

Publications: